
Dave’s Analysis 6/23/2025
Company Overview: Immunic Inc. (NASDAQ: IMUX) Immunic Inc. is a clinical-stage biopharmaceutical company pioneering the development of selective, orally administered immunology therapies. Headquartered in New York City (formerly San Diego),





